Abstract
Embryogenesis is a period during which cells are exposed to dynamic changes of various intracellular and extracellular stresses. Oxidative stress response genes are regulated by heterodimers composed of Cap'n'Collar (CNC) and small Maf proteins (small Mafs) that bind to antioxidant response elements (ARE). Whereas CNC factors have been shown to contribute to the expression of ARE-dependent cytoprotective genes during embryogenesis, the specific contribution of small Maf proteins to such gene regulation remains to be fully examined. To delineate the small Maf function in vivo, in this study we examined mice lacking all three small Mafs (MafF, MafG, and MafK). The small Maf triple-knockout mice developed normally until embryonic day 9.5 (E9.5). Thereafter, however, the triple-knockout embryos showed severe growth retardation and liver hypoplasia, and the embryos died around E13.5. ARE-dependent cytoprotective genes were expressed normally in E10.5 triple-knockout embryos, but the expression was significantly reduced in the livers of E13.5 mutant embryos. Importantly, the embryonic lethality could be completely rescued by transgenic expression of exogenous MafG under MafG gene regulatory control. These results thus demonstrate that small Maf proteins are indispensable for embryonic development after E9.5, especially for liver development, but early embryonic development does not require small Mafs.
INTRODUCTION
Oxidative stress causes damage to DNA, proteins, and lipids and causes or exacerbates various human diseases, including cancers (e.g., reviewed in reference 30). However, cells usually do not succumb to such stresses, as cells retain machinery that acts to minimize oxidative damage by inducing cytoprotective defense enzymes. Indeed, several transcription factor families have been identified as important regulators of cytoprotective genes related to the oxidative stress response and redox homeostasis (reviewed in reference 4). One such transcription factor family is the Cap'n'Collar (CNC) proteins (reviewed in reference 22), which exert their function by forming a heterodimer with small Maf family members (9). Three small Maf proteins (small Mafs), MafF, MafG, and MafK, have been identified in mammals (reviewed in reference 21), and an additional member of the family, MafT, has been identified in fish (37). The CNC-small Maf heterodimers bind to cis-acting motifs named the Maf recognition element (MARE) (13), NF-E2 binding motif (31), antioxidant response element (ARE) (32), or the electrophile response element (EpRE) (5). The latter two cis-acting motifs represent similar binding motifs that have been identified in the regulatory regions of numerous genes encoding antioxidant and xenobiotic-metabolizing enzymes (11). Regulation of gene expression through the ARE and EpRE motifs has been shown to be critical for the oxidative stress response, and the CNC-small Maf heterodimers are the transcription factors attributable to that regulation (10).
The CNC family is composed of four closely related transcription factors, p45 NF-E2, Nrf1, Nrf2, and Nrf3, as well as two related factors, Bach1 and Bach2. The in vivo functions of CNC proteins have been elucidated by gene targeting in the mouse. In Nrf2 knockout mice, induction of a battery of antioxidant and xenobiotic-metabolizing enzyme genes are severely impaired (11). Nrf1 knockout mice exhibit fetal liver hypoplasia coincident with diminished ARE-dependent cytoprotective gene expression (2, 3). Recently, mouse genetic approaches revealed that p45 NF-E2, which is known to be critical for platelet production, contributes to the activation of ARE-dependent antioxidant genes in megakaryocytes (25). Thus, the CNC family transcription factors play important and likely overlapping roles in the regulation of ARE-dependent genes in vivo.
The small Mafs have been shown to be critical for the CNC factor binding to specific cis-acting motifs (reviewed in reference 22). The NF-E2 binding motif and ARE/EpRE motif are all encompassed by either 13-bp or 14-bp MARE sequences, which are composed of a central core and flanking regions. The central core sequence is identical to either the tumor-promoter response element (TRE; 13-bp type) or cyclic AMP (cAMP) response element (CRE; 14-bp type), while the flanking sequence harbors a critical GC sequence required for site binding. Recent structural and biophysical analyses revealed that the small Mafs specifically recognize these GC sequences, whereas the CNC proteins bind to the core sequence (18, 40). The acquisition of the flanking GC binding by small Mafs has rendered the CNC-small Maf heterodimers to recognize a totally distinct set of target genes differing from those of the AP1 or CREB/ATF family members (18, 40). Target genes regulated by the CNC-small Maf heterodimers are important for hematopoiesis (p45 NF-E2-small Mafs) and stress response/cytoprotective gene expression (Nrf2/Nrf1/Bach1-small Mafs). However, any physiological contribution of the small Mafs to cytoprotective gene expression has not been elucidated in vivo.
In order to examine the roles small Mafs play in vivo, we and others have ablated each member of small Maf family proteins individually in mice (17, 28, 33). We found that MafG knockout mice showed mild thrombocytopenia and motor ataxia, while MafF and MafK knockout mice did not show apparent phenotypes. Since small Maf proteins are functionally redundant and expressed in an overlapping manner, we surmised that remaining small Maf protein expression compensated for the lost function of any individual. Supporting this notion, MafG MafK double-knockout mice display severe thrombocytopenia and neurological phenotypes and die before weaning (14, 16, 29).
To delineate the contribution of small Maf proteins in the absence of complementation by other family members, we generated small Maf triple-knockout mice, bearing mutations in all six alleles (i.e., MafF−/− MafG−/− MafK−/−). During the course of the study, we found that small Maf triple-knockout mice were embryonic lethal (15). Therefore, we established mouse embryonic fibroblasts (MEFs) derived from the triple-knockout embryos and found that the induction of cytoprotective genes was severely compromised in the triple-knockout fibroblasts (15). Based on this result, we speculated that experiments attempting to decipher the phenotypes of small Maf triple-knockout mice might provide insight into the nature of CNC-small Maf heterodimer-mediated stress responses in the context of multilayered defense mechanisms. However, the exact phenotype of small Maf triple-knockout embryos and the contribution of small Mafs to gene expression in vivo remained to be clarified.
In this study, we analyzed in detail the phenotypes of small Maf triple-knockout mice, especially with regard to the regulation of ARE-dependent cytoprotective genes. We found that small Maf triple-knockout mice developed normally up to embryonic day 8.5 (E8.5), but found that the small Mafs are essential for embryonic development beyond E9.5. The small Maf triple-knockout mice exhibited growth retardation from E9.5 onward and died around E13.5. The mutant embryos showed severe hypoplasia in the fetal liver due to increased apoptosis of hepatocytes and erythrocytes. The expression of cytoprotective genes was decreased in the mutant livers, possibly leading to increased apoptosis. The embryonic lethality and liver hypoplasia observed in the small Maf triple-knockout mice could be completely rescued by transgenic expression of exogenous MafG. These observations thus demonstrate that small Maf-mediated gene expression is indispensable for the maintenance of fetal liver hepatocytes, but surprisingly, early embryogenesis to E8.5 appears to proceed normally without any contribution from the small Maf proteins.
MATERIALS AND METHODS
Generation of compound mutant mice.
Germ line mutagenesis of the mouse MafF, MafG, and MafK genes was performed as described previously (28, 33). LoxP-flanked PGK-neo/TK or PGK-neo cassettes in all targeted alleles were removed by mating with Ayu1-Cre mice (26). All mice examined in this study were of a mixed background, with contributions from the 129Sv/J, C57BL/6J, and ICR strains. Genotypes were determined by PCR as described previously (28, 33). The body weight of each mouse was measured weekly. More than three independent animals of each genotype were first weighed on postnatal day 7 and then monitored to the 6th week.
Hematological analysis.
Thirty to 50 microliters of peripheral blood was collected from individual 8- to 10-week-old mice. Hematopoietic indices were determined using a hemocytometer (Nihon Koden, Tokyo, Japan). Liver cells from E13.5 embryos were suspended in 2% fetal bovine serum/phosphate-buffered saline, and counted on a hemocytometer.
Quantitative RT-PCR.
For quantitative reverse transcription-PCR (RT-PCR), total RNA was prepared from mouse embryo or fetal livers using an Isogen RNA extraction kit (Nippon Gene, Toyama, Japan) and following the manufacturer's protocol. cDNA was synthesized from total RNA by reverse transcriptase Superscript III (Invitrogen), and real-time PCR was performed using an ABI prism 7300 (Applied Biosystems), as previously described (28). The primer and probe sequences used for detecting Nqo1, glutathione S-transferase (GST) alpha 4 (Gsta4), Gst pi 1 (Gstp1), Gst pi 2 (Gstp2), thioredoxin reductase 1 (Txnrd1), Gclc, heme oxygenase 1 (Hmox1), and multidrug resistance proteins (Mrp2, Mrp3, Mrp4, and Mrp5) have been described previously (15, 27, 41). The rRNA primers and probes were purchased from Applied Biosystems.
Histological analysis.
Whole embryos were fixed with 10% formalin (Mildform 10N; Wako, Tokyo) and embedded in paraffin using standard procedures. Sections (5 μm) were stained with hematoxylin-eosin. For single staining of cleaved caspase-3, anti-cleaved caspase-3 (Cell Signaling Technology) antibody was used. Diaminobenzidine was used as a chromogen, and hematoxylin was used for counterstaining. For double immunostaining, E13.5 livers were embedded in OCT compound (Sakura-Finetechnical, Tokyo, Japan). The frozen sections (7 μm) were fixed with 3% formalin. To detect erythroid cells and hepatocytes, anti-Ter119 (Becton Dickinson) and anti-delta-like homolog 1 (Dlk-1) (Medical and Biological Laboratories, Nagoya, Japan) antibodies were used, respectively. Visualization was performed using Alexa Fluor 488 for Ter119 and Dlk-1 and Alexa Fluor 594 for cleaved caspase-3 (Molecular Probes). Each first antibody was diluted to 1:200. Fluorescent images were observed using the LSM510 confocal imaging system (Carl Zeiss, Heidelberg, Germany).
Microarray analyses and data mining.
Total RNA purified from mouse embryos was processed and hybridized to a whole-mouse genome microarray (4 × 44K; Agilent Technologies). Experimental procedures for Gene Chip were performed according to the manufacturer's protocol. Expression data were subjected to analysis with GeneSpring software (Silicon Genetics). Heat maps were generated by using Cluster 3.0 (http://bonsai.hgc.jp/∼mdehoon/software/cluster/) and JAVA Treeview (http://jtreeview.sourceforge.net/). The pathway analysis was performed using the Reactome pathway enrichment tool (http://www.reactome.org).
Plasmid construction for transgenic mouse analysis.
To construct MGRD-LacZ and MGRD-MafG (where MGRD represents MafG regulatory domain), p2.9MafG-LacZ was first generated by subcloning a genomic fragment from the mouse MafG gene; SmalI-SmaI (kbp −2.9 to bp −8, with the translation start site designated +1) into the blunt-ended XhoI site of pSVβ (Clontech). The blunt-ended genomic fragment from the 3′ region of the MafG gene, NcoI (at kbp +1.1) to SphI (at kbp +4.8), was then inserted into the blunt-ended SalI site of p2.9MafG-LacZ to generate p2.9MafG-LacZ-3′. MGRD-LacZ was constructed by replacing the EcoRI-AflII fragment of p2.9MafG-LacZ-3′ with the 5.1-kbp fragment from the upstream region of the AflII site (at kbp −1.7) of the MafG genome. A LacZ cDNA was replaced with a histidine-tagged MafG cDNA (24) to generate MGRD-MafG.
Generation of transgenic mice.
Transgene constructs were injected into C57BL/6 × BALB/c fertilized eggs. Transgenic mice were generated by standard methods (8). MafF−/− MafG+/− MafK−/− (F0G1K0) mice bearing the MGRD-MafG transgene (TGMafG mice) were mated with F0G1K0 mice to generate F0G0K0:TGMafG mice. Genotypes were determined by PCR with a primer set for the MGRD-LacZ transgene (TGLacZ construct) (5′-GCA TGA CTC GCC AGG AAC AG-3′ and 5′-GCA ACG AAA ATC ACG TTC TTG TTG G-3′) and a primer set for the TGMafG construct (5′-AAG AAG GAG ATA TAC CAT GGG-3′ and 5′-GCA TTC TCC GAG GCC AGC TTC-3′).
Whole-mount LacZ staining.
Mouse embryos were fixed at room temperature for 60 min in 1% formaldehyde, 0.2% glutaraldehyde, and 0.02% NP-40 in phosphate-buffered saline. 5-Bromo-4-chloro-3-indolyl-β-d-galactosidase (X-Gal) staining was performed as previously described (33).
Microarray data accession number.
The microarray data are available through the Gene Expression Omnibus database (accession no. GSE29558).
RESULTS
Generation of MafF−/− MafG−/− MafK−/− (F0G0K0) triple-knockout mice.
In order to establish an efficient way to generate small Maf triple-knockout mice, we first asked whether animals harboring single-copy small Maf genes could become fertile adults. As summarized in Fig. 1A, it was found previously that, while MafF+/+ MafG−/− MafK−/− (F2G0K0) and MafF−/− MafG−/− MafK+/+ (F0G0K2) mice exhibit anemia, thrombocytopenia, and ataxia (14, 29, 33), MafF−/− MafG+/+ MafK−/− (F0G2K0) mice are relatively healthy and fertile (23). Based on these observations, in this study we first examined the phenotypes of F0G1K0 mice as candidates to generate the small Maf triple-knockout mice. We found that the F0G1K0 mice exhibited mild hypochromic anemia and thrombocytopenia (Fig. 1B), perhaps due to impairment of the NF-E2 activity in the erythroid and megakaryocytic lineages (35). However, the F0G1K0 mice did not exhibit any severe growth abnormality (Fig. 1C) or ataxia (data not shown). Most importantly, the F0G1K0 mice were fertile and lived long enough to reproduce. These results demonstrate that one allele of the MafG gene is sufficient to sustain growth, survival, and fertility of mice. Hence, we decided to establish a breeding colony of F0G1K0 mice to produce the small Maf triple-knockout mice efficiently (Fig. 1D).
Fig 1.
F0G1K0 mice show no severe abnormality and are capable of producing small Maf triple-knockout mice. (A) Summary of phenotypes of small Maf double-knockout mice (14, 23, 28, 29, 33). Abnormalities were arbitrarily categorized into four groups: severe, +++; mild, ++; very mild, +; none. N.D., not determined. (B) Blood parameters in wild-type (WT), F0G2K0, and F0G1K0 mice. Values are means ± standard deviations (n = 7 for wild-type mice, n = 8 for F0G2K0 mice, n = 6 for F0G1K0 mice). Student's t test was used to calculate statistical significance (P). *, P < 0.05; **, P < 0.01. (C) Body weight change for F0G2K0 and F0G1K0 mice. Values are means ± standard deviations (n = 3 to 4) (D) Mating strategy for producing small Maf triple-knockout mice. RBC, red blood cells; HGB, hemoglobin; HCT, hematocrit; MCV, mean cell volume; MCH, mean cell hemoglobin; PLT, platelet.
Small Maf triple-knockout mice exhibit growth retardation and embryonic lethality.
We intercrossed the F0G1K0 mice and recovered 94 2-week-old mice. According to Mendelian law, the expected number of F0G0K0 mice in the progeny of this intercross was 23 or more. However, no F0G0K0 mice survived to this stage (Table 1). To characterize timing of the lethality, we conducted timed F0G1K0 intercrosses and collected embryos at different stages of gestation (Table 2). We found F0G0K0 embryos at the expected Mendelian frequency at E8.5. However, after E9.5 the frequency of F0G0K0 embryos became lower than expected, and some of the F0G0K0 embryos exhibited growth retardation (Fig. 2A, top panels). At E10.5, 33 out of 46 F0G0K0 embryos showed growth retardation, whose severity varied greatly (data not shown). By E11.5, 13 out of 17 F0G0K0 embryos exhibited severe growth retardation (Fig. 2A, middle panels). F0G0K0 embryos are also pale compared with F0G2K0 embryos at E13.5, implying that the embryos began to encounter inefficient hematopoiesis. At E13.5, 11/50 compound homozygous mutant embryos were recovered, and all of them showed severe growth retardation (Fig. 2A, bottom panels), indicating that most of the F0G0K0 embryos died around E13.5. However, the timing of death was not precise, but rather was distributed widely during midgestation (Table 2).
Table 1.
Genotypes of viable offspring from F0G1K0 mouse intercrosses
| Parameter at 2 wk | No. of offspring of genotype: |
Total | ||
|---|---|---|---|---|
| F0G2K0 | F0G1K0 | F0G0K0 | ||
| Predicted | 24 | 47 | 24 | 95 |
| Observed | 32 | 62 | 0 | 94 |
Table 2.
Genotypes of viable offspring from F0G1K0 mouse intercrosses
| Stage and parameter | No. of offspring of genotypea: |
Total | ||
|---|---|---|---|---|
| F0G2K0 | F0G1K0 | F0G0K0 | ||
| E8.5 | ||||
| Predicted | 11 | 21 | 11 | 43 |
| Observed | 10 | 24 | 9 | 43 |
| E9.5 | ||||
| Predicted | 19 | 39 | 19 | 77 |
| Observed | 24 (1) | 42 (2) | 11 (6) | 77 |
| E10.5 | ||||
| Predicted | 67 | 134 | 67 | 268 |
| Observed | 87 (6) | 135 (2) | 46 (33) | 268 |
| E11.5 | ||||
| Predicted | 25 | 50 | 25 | 100 |
| Observed | 22 | 61 (1) | 17 (13) | 100 |
| E12.5 | ||||
| Predicted | 19 | 37 | 19 | 75 |
| Observed | 24 (2) | 43 (1) | 7 (5) | 74 |
| E13.5 | ||||
| Predicted | 50 | 99 | 50 | 199 |
| Observed | 73 | 115 (1) | 11 (11) | 199 |
| E14.5 | ||||
| Predicted | 8 | 16 | 8 | 32 |
| Observed | 10 | 20 | 2 (2) | 32 |
| E15.5 | ||||
| Predicted | 12 | 24 | 12 | 48 |
| Observed | 17 | 30 | 1 (1) | 48 |
The numbers of embryos exhibiting growth retardation are shown in parentheses.
Fig 2.

F0G0K0 embryos show growth retardation and hypoplasia in fetal livers (A) Representative pictures of embryos with or without yolk sac at different developmental time points. The genotypes and gestational ages of the embryos are indicated. (B) Representative pictures of fetal livers for each genotype at E13.5. (C) Total cell numbers per fetal liver for each genotype at E13.5. Values are means ± standard deviations (n = 3 to 5). Student's t test was used to calculate statistical significance (P). **, P < 0.01.
During the course of embryo analyses, we observed one significant distinction in the mutants. The livers of F0G0K0 embryos were very small compared to those of F0G2K0 embryos (Fig. 2B), and the cell numbers in the livers were significantly reduced (Fig. 2C). All F0G0K0 embryos exhibited diminished liver size (11 out of 11) (data not shown), while the sizes of other major organs, such as the heart or brain, were not severely affected (data not shown). These results demonstrate that the small Mafs are dispensable for early embryonic development up to E8.5, but they are essential for embryonic development beyond E13.5, and furthermore, they appear to be indispensable for fetal liver development.
Small Mafs contribute to the expression of cytoprotective genes in the fetal liver.
It has been reported that Nrf1 knockout mice exhibit growth retardation and severe hypoplasia in fetal livers, in which the expression of oxidative stress response genes was diminished (2, 3). Therefore, we surmised that the expression of ARE-dependent cytoprotective genes might be compromised in the F0G0K0 embryo livers. We examined the expression of these cytoprotective genes and found that expression levels of many ARE-dependent genes (e.g., Gclc, Txnrd1, Nqo1, Gstp2, and several Mrp genes) were lower in the livers of F0G0K0 embryos than in F0G2K0 livers (Fig. 3).
Fig 3.
Expression profiles of antioxidant and xenobiotic-metabolizing enzyme genes in fetal livers at E13.5. Gene expression was examined by quantitative RT-PCR. The genotypes of the embryos are indicated. The expression level of each mRNA was normalized to the rRNA abundance. The average values of F0G2K0 mice are set to 1. Values are means ± standard deviations (n = 3 to 5). Student's t test was used to calculate statistical significance (P). *, P < 0.05; **, P < 0.01.
We also examined the embryonic livers histologically. Hematoxylin-eosin staining of E13.5 F0G2K0 embryo livers showed normal sinusoidal structure (Fig. 4A), which was severely damaged in the F0G0K0 livers (Fig. 4B). Immunostaining of an apoptosis marker (cleaved caspase-3) clearly demonstrated the presence of apoptotic cells in F0G0K0 fetal livers. The number of apoptotic cells was markedly higher in the F0G0K0 embryo livers (Fig. 4D) than in F0G2K0 livers (Fig. 4C). Double immunostaining with hematopoietic maker Ter119 or hepatic marker Dlk-1 (38) showed that apoptotic cells were observed in both the Ter119-positive cell fraction (Fig. 4E to H) and Dlk-1-positive cell fraction (Fig. 4I to L), suggesting that fetal liver hematopoiesis is impaired in F0G0K0 embryos. Taken together, these results suggested that the basal expression of ARE-dependent genes in fetal livers is dependent on small Mafs, and this alteration could be one of possible causes of liver hypoplasia in F0G0K0 embryos.
Fig 4.
Apoptosis observed in fetal livers of F0G0K0 embryos at E13.5. (A and B) Hematoxylin-eosin (HE) staining of fetal livers of F0G2K0 and F0G0K0 embryos. (C and D) Immunohistochemistry for cleaved caspase-3 in fetal livers of F0G2K0 and F0G0K0 embryos. Scale bar corresponds to 50 μm. (E to L) Double-immunofluorescence staining of cleaved caspase-3 (red) and Ter119 (green) or Dlk-1 (green). Nuclear DAPI (4′,6-diamidino-2-phenylindole) staining is shown in blue. The merge images of E to G and I to K are shown in panels H and L, respectively.
The expression of ARE-dependent cytoprotective genes is preserved in E10.5 F0G0K0 embryos.
The growth retardation is apparent in E10.5 F0G0K0 embryos where livers are not yet formed (Table 2), supporting the contention that fetal liver hypoplasia may not account for the growth retardation in the mutants. To explore the cause of growth retardation observed in E10.5 F0G0K0 embryos, we carried out a microarray analysis of gene expression at this stage. To eliminate differences simply caused by developmental delay, we compared the gene expression profile of E10.5 F0G0K0 embryos with those of both E9.5 and E10.5 F0G2K0 embryos. Our initial hypothesis was that the dysregulation of ARE-dependent cytoprotective gene expression might be a cause of growth retardation. However, the expression levels of many ARE-dependent cytoprotective genes in F0G0K0 embryos were comparable to those in F0G2K0 embryos (Table 3).
Table 3.
Microarray analysis of ARE-dependent gene expression in F0G2K0 and F0G0K0 embryos
| Gene product | Description | Fold increase in expression in embryosa: |
|
|---|---|---|---|
| E10.5 F0G0K0/E10.5 F0G2K0 | E10.5 F0G0K0/E9.5 F0G2K0 | ||
| Gclc | Glutamylcysteine ligase, catalytic subunit | 1.2 | 1.0 |
| Gclm | Glutamylcysteine ligase, modulator subunit | 1.6 | 1.9 |
| Gpx1 | Glutathione peroxidase 1 | −1.1 | 1.0 |
| Gpx2 | Glutathione peroxidase 2 | −1.2 | 1.0 |
| Gsta3 | Glutathione S-transferase A3 | −1.5 | −1.5 |
| Gsta4 | Glutathione S-transferase A4 | 1.0 | 1.0 |
| Gstm1 | Glutathione S-transferase M1 | 1.1 | 1.1 |
| Gstm2 | Glutathione S-transferase M2 | −1.1 | 1.0 |
| Gstm3 | Glutathione S-transferase M3 | −1.1 | −1.1 |
| Gstm4 | Glutathione S-transferase M4 | 1.1 | 1.1 |
| Gstm5 | Glutathione S-transferase M5 | 1.0 | 1.0 |
| Gstp1 | Glutathione S-transferase P1 | 1.1 | 1.0 |
| Hmox1 | Heme oxygenase 1 | 2.6 | 2.7 |
| Nqo1 | NAD(P)H:quinone oxidoreductase | −1.8 | −1.1 |
| Prdx1 | Peroxiredoxin 1 | 1.1 | −1.1 |
| Txnrd1 | Thioredoxin reductase 1 | 1.0 | −1.1 |
Each value indicates the fold increase in the gene expression of F0G0K0 embryos at E10.5 relative to that of F0G2K0 embryos at E10.5 or F0G0K0 embryos at E10.5 relative to that of F0G2K0 embryos at E9.5.
To confirm the microarray data, we selected several ARE-dependent cytoprotective genes and performed quantitative RT-PCR analysis. In agreement with the microarray data, Nqo1, Gsta4, Txnrd1, and Gclc genes were normally expressed in F0G0K0 embryo livers compared with those of F0G2K0 embryos (Fig. 5). Hmox1 gene expression was rather increased in F0G0K0 embryos (Fig. 5), suggesting that small Mafs negatively regulate the Hmox1 gene at this stage (15). These results thus demonstrate that the small Mafs are dispensable for the basal expression of these ARE-dependent cytoprotective genes at an early embryonic stage, and their diminished expression is not the cause of the growth retardation observed in the E10.5 embryos.
Fig 5.
Expression profiles of antioxidant and xenobiotic-metabolizing enzyme genes in F0G2K0 and F0G0K0 embryos. Gene expression was examined by quantitative RT-PCR. The genotypes and gestational ages of the embryos are indicated. The expression level of each mRNA was normalized to the rRNA abundance. The average values of F0G2K0 embryos at E10.5 are set to 1. Values are means ± standard deviations (n = 3 to 6). Student's t test was used to calculate statistical significance (P). *, P < 0.05; **, P < 0.01.
Exploration of small Maf-dependent genes in embryos.
To explore potential causes of growth retardation or lethality in F0G0K0 embryos, we first focused on genes whose expression were decreased more than 2.0-fold in E10.5 F0G0K0 embryos in comparison with both E10.5 and E9.5 F0G2K0 embryos. Pathway analysis revealed that genes related to hemostasis were strongly enriched in the downregulated genes (see Table S1 in the supplemental material). We also noticed that there are several genes acting downstream of p45 NF-E2 (25), suggesting that small Maf deficiency affected p45 NF-E2-dependent gene expression (Fig. 6). However, these genes seem not to be the primary cause of the lethality, as p45 NF-E2 knockout mice survive until birth (35). There are other genes that may cause the phenotype, such as genes involved in cell adhesion and receptor/channel and signal transduction (Fig. 6). Genes increased in F0G0K0 embryos may also be associated with the phenotypes (see Fig. S1 in the supplemental material), since the Bach1-small Maf heterodimer is known to act as a repressor (36).
Fig 6.
Heat map of relative expression levels of genes decreased in E10.5 F0G0K0 embryos in comparison with both E10.5 and E9.5 F0G2K0 embryos (over 2.0-fold). Heat map colors indicate normalized expression level (log2). Genes were categorized by function. Closed circles indicate genes involved in hemostasis according to pathway analysis. Open circles indicate genes that act downstream of p45 NF-E2 (25).
Rescue of small Maf triple-knockout mice by transgenic expression of MafG.
It is important to note that the F0G0K0 embryos examined in this study were derived from single lines of embryonic stem (ES) cells that were deficient for MafF, MafG, or MafK. Hence, there exists a formal possibility that unrelated mutations generated during the course of creating the mutants might affect the phenotype observed in F0G0K0 embryos. To address this formal possibility and test the contention that the abnormalities observed in F0G0K0 embryos are truly caused by the loss of small Mafs, we attempted a transgenic complementation rescue analysis. To this end, we decided to rescue the F0G0K0 mice by transgenic expression of the MafG protein, since a single wild-type allele of MafG appeared to be sufficient to avoid embryonic lethality and to sustain fertility of adult mice.
To utilize the MafG gene regulatory region for transgene construct, we isolated genomic sequences including the MafG gene and examined their activity using a LacZ reporter gene to generate transgenic mice. We generated and examined transgenic mouse lines expressing the β-galactosidase reporter under the regulation of MafG (Fig. 7A). We found that a genomic segment covering 6.8 kbp upstream and 4.8 kbp downstream of MafG gene nicely recapitulated the endogenous MafG gene expression pattern, which could be assessed by the examination of the LacZ gene knock-in into the MafG locus (33). Accordingly, we designated this genomic region as MafG regulatory domain (MGRD). MGRD-mediated β-galactosidase expression was observed broadly in the transgenic embryos, and this was similar to the pattern observed in LacZ/MafG knock-in mice (Fig. 7B).
Fig 7.
Small Maf triple-knockout mice were rescued by transgenic expression of MafG. (A) Schematic structure of the MGRD-LacZ transgene. The mouse MafG wild-type (WT) allele is depicted at the top. The MafG knockout (KO) allele is shown beneath the wild-type locus. (B) Whole-mount LacZ staining in WT, MafG+/−, and TGLacZ embryos at E10.5 (C) The mating strategy for producing F0G0K0 mice rescued by TGMafG mice (F0G0K0:TGMafG mice). (D) Representative pictures of F0G1K0, F0G0K0, and F0G0K0:TGMafG embryos at E13.5 with or without yolk sac. (E) Representative pictures of fetal livers for each genotype at E13.5.
Finally, we generated transgenic mice expressing an exogenous MafG cDNA under the regulation of MGRD (TGMafG mice) and bred the transgenic mice into an F0G0K0 background. To this end, several crosses of TGMafG mice with F0G1K0 mice were conducted, as shown in Fig. 7C. At embryonic stages, rescued embryos (F0G0K0:TGMafG mice) exhibited normal growth and liver development (Fig. 7D and E). No signs of anemia or growth retardation were observed. Moreover, rescued mice were born at the expected Mendelian frequency and showed no behavioral or hematological abnormalities (data not shown). Taken together, these results demonstrate that the E13.5 embryonic lethality and liver dysplasia observed in F0G0K0 embryos are a result of the loss of function of all small Mafs in the mouse.
DISCUSSION
The CNC family of transcription factors activates unique sets of target genes through heterodimerizing with small Mafs. Contributions of the CNC proteins to the expression of ARE-dependent cytoprotective genes have been demonstrated by means of loss-of-function and/or gain-of-function analyses based on the mouse genetics (3, 11, 19, 25, 39). However, the contributions of small Mafs to those partnerships have not been addressed in vivo. Therefore, in this study we examined the phenotypes of F0G0K0 mice and delineated how small Mafs participate in ARE-dependent cytoprotective gene regulation. While the small Maf triple-knockout (F0G0K0) mice appeared to develop normally up to E8.5, the embryos exhibited severe growth retardation, and all embryos died by E13.5. The F0G0K0 embryos showed severe liver hypoplasia, and expression of ARE-dependent cytoprotective genes in the liver was profoundly reduced. Contrary to the observation in E13.5 livers, most ARE-dependent cytoprotective genes were normally expressed in E10.5 F0G0K0 embryos. These results thus demonstrate that the small Mafs are essential for embryonic development after E9.5, especially for the development of the fetal liver.
This study provides the first evidence that the small Mafs are required and functional during mid-embryogenesis. Since none of the small Maf gene single- or double-knockout mice exhibit embryonic lethality (23, 28, 29, 33), it has been assumed that small Mafs are functionally redundant during embryonic stages. Even if individual small Maf genes are required to drive transcription of critical target genes during embryogenesis, the other small Mafs complement the loss of function of any individual small Maf protein. However, in adult animals, MafG is the only small Maf protein enabling mice to survive without severe abnormalities (Fig. 1) (23). Furthermore, we showed in this study that F0G1K0 mice bearing only a single active MafG allele are fertile to maturity (Fig. 1). The reason for the differences in the activities of the small Mafs is currently unknown. One plausible explanation may be due to the differences in the expression profiles of small Maf genes, as the MafG gene shows the broadest expression profile among the small Maf genes (28). These observations thus support the notion that MafG is the most critical of the small Mafs in adult stages.
As summarized in Fig. 8, the phenotypes of the small Maf triple-knockout embryos are very similar to those observed in Nrf1 Nrf2 double-knockout embryos that exhibit growth retardation and die between E9.5 and E13.5 (19). This observation supports the notion that Nrf1 and Nrf2 require small Mafs as obligatory partners. Additionally, fetal liver hypoplasia is a common phenotype observed in both small Maf triple-knockout and Nrf1 knockout embryos (2), suggesting the importance of Nrf1-small Maf heterodimers in the maintenance of fetal liver homeostasis. Interestingly, other stress-inducible transcription factors, such as RelA, c-Jun, and MTF-1, have been reported to be indispensable for the growth or maintenance of fetal mouse livers (1, 6, 7). Since the fetal liver may be an organ that suffers from a variety of multiple stresses, development of the organ may rely on many different stress-inducible pathways, including the CNC-small Maf heterodimer.
Fig 8.
Comparison of phenotypes in gene-targeting mice showing embryonic lethality. Mouse embryonic stages are shown at the top with schematic images of embryos (not in the correct scale). Fetal livers are depicted as the pink areas. Horizontal arrows indicate the survival periods of each knockout mouse. The blue line represents the period without abnormality, and the red dotted line means the period with abnormality, such as growth retardation. Nrf2 knockout mice are viable and fertile, although induction of cytoprotective genes is impaired in these mice (11). The majority of p45 NF-E2 knockout mice die during perinatal period (35). Nrf1 knockout mice display growth retardation after E10.5 and die by E18.5 (2). Both F0G0K0 and Nrf1 Nrf2 double-knockout mice display growth retardation after E9.5 and die by E13.5 (19). Trxrd1 knockout mice die around E9.5 (12). Gclc knockout mice die around E8.5 (34).
It should be noted that there are significant discrepancies in the phenotypes of the small Maf triple-knockout embryos and Nrf1 Nrf2 double-knockout embryos. Whereas apoptosis was broadly observed in the Nrf1 Nrf2 double-knockout embryos (19), severe apoptosis was only significant in the livers of F0G0K0 embryos. The phenotypes of F0G0K0 embryos are also milder than those of Nrf1 Nrf2 double-knockout embryos. This may be due to the impairment of Bach1 functions in the small Maf triple-knockout mice. Bach1-small Maf heterodimers are known to negatively regulate the expression of Hmox1 (36), and heme oxygenase-1 is derepressed in the F0G0K0 embryos (15). Since heme oxygenase-1 is known to act as an antioxidant enzyme (20), the activation of Hmox1 gene expression might alleviate the phenotypes of F0G0K0 embryos compared to the Nrf1 Nrf2 double-knockout embryos.
To our surprise, ARE-dependent cytoprotective genes were expressed at a comparable level to wild-type embryos in the small Maf triple-knockout embryos at E10.5. These cytoprotective genes include several critical genes whose disruption results in far more severe defects in embryogenesis than those in the small Maf triple-knockout embryos. For example, as summarized in Fig. 8, Gclc gene mutant mice die by E8.5 with defects in gastrulation (34), and Txnrd1 knockout mice die by E10.5 with growth retardation and reduced proliferation (12). Thus, expression of these cytoprotective genes is indispensable for early embryogenesis, but this study clearly demonstrates that the expression of these genes is maintained in a small Maf-independent manner in E10.5 embryos. There may be two possibilities to explain this phenomenon. One is that Nrf1 and Nrf2 can induce the expression of ARE-dependent cytoprotective genes without forming heterodimers with small Mafs at this stage. The other is that in early to midgestation embryos, cytoprotective genes are not under the regulation of CNC-small Maf heterodimers, implying the presence of a multilayered regulatory system that controls the cytoprotective genes. However, it is important to note that severe growth retardation is already evident in E10.5 small Maf triple-knockout embryos. This observation suggests that by this stage the small Mafs contribute to the regulation of critical genes that are distinct from typical ARE-dependent cytoprotective genes. Understanding the function of small Mafs during this period of embryogenesis would be an important future objective.
In conclusion, we have demonstrated that early embryogenesis proceeds without the contribution of small Mafs, but small Mafs are essential for embryogenesis beyond E9.5, especially in fetal liver development. The livers of small Maf triple-knockout embryos show severe apoptosis, which resembles the livers of Nrf1 Nrf2 double-knockout embryos. This study thus revealed that the small Maf triple-knockout embryos phenocopy the Nrf1 Nrf2 double-knockout embryos, and these results further support the contention that CNC proteins require small Mafs as obligatory partner molecules.
Supplementary Material
ACKNOWLEDGMENTS
We are grateful to M. Suzuki for advice and helpful comments. We thank Y. Kawatani and Y. Kurokouchi for assistance with the microarray analysis, E. Naganuma and the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support, and laboratory members for useful discussions.
This work was supported in part by grants from the Japan Society for the Promotion of Science (to M.Y. and F.K.), the Ministry of Education, Science, Sports, and Culture, the Takeda Foundation, the Naito Memorial Foundation, and the Tohoku University Global COE Program for Conquest of Signal Transduction Diseases with “Network Medicine” (to M.Y.).
Footnotes
Published ahead of print 12 December 2011
Supplemental material for this article may be found at http://mcb.asm.org/.
REFERENCES
- 1. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167–170. [DOI] [PubMed] [Google Scholar]
- 2. Chan JY, et al. 1998. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J. 17:1779–1787 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Chen L, et al. 2003. Nrf1 is critical for redox balance and survival of liver cells during development. Mol. Cell. Biol. 23:4673–4686 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Covarrubias L, Hernández-García D, Schnabel D, Salas-Vidal E, Castro-Obregón S. 2008. Function of reactive oxygen species during animal development: passive or active? Dev. Biol. 320:1–11 [DOI] [PubMed] [Google Scholar]
- 5. Friling RS, Bensimon A, Tichauer Y, Daniel V. 1990. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. U. S. A. 87:6258–6262 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Günes C, et al. 1998. Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-1. EMBO J. 17:2846–2854 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Hilberg F, Aguzzi A, Howells N, Wagner EF. 1993. c-jun is essential for normal mouse development and hepatogenesis. Nature 365:179–181 [DOI] [PubMed] [Google Scholar]
- 8. Hogan B, Constantini F, Lacy E. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY [Google Scholar]
- 9. Igarashi K, et al. 1994. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 367:568–572 [DOI] [PubMed] [Google Scholar]
- 10. Ishii T, et al. 2000. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275:16023–16029 [DOI] [PubMed] [Google Scholar]
- 11. Itoh K, et al. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:313–322 [DOI] [PubMed] [Google Scholar]
- 12. Jakupoglu C, et al. 2005. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol. Cell. Biol. 25:1980–1988 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Kataoka K, Noda M, Nishizawa M. 1994. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol. Cell. Biol. 14:700–712 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Katsuoka F, et al. 2003. Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response. Mol. Cell. Biol. 23:1163–1174 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Katsuoka F, et al. 2005. Genetic evidence that small Maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol. Cell. Biol. 25:8044–8051 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Kobayashi A, et al. 2011. Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction. Genes Cells 16:692–703 [DOI] [PubMed] [Google Scholar]
- 17. Kotkow KJ, Orkin SH. 1996. Complexity of the erythroid transcription factor NF-E2 as revealed by gene targeting of the mouse p18 NF-E2 locus. Proc. Natl. Acad. Sci. U. S. A. 93:3514–3518 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Kurokawa H, et al. 2009. Structural basis of alternative DNA recognition by Maf transcription factors. Mol. Cell. Biol. 29:6232–6244 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Leung L, Kwong M, Hou S, Lee C, Chan JY. 2003. Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J. Biol. Chem. 278:48021–48029 [DOI] [PubMed] [Google Scholar]
- 20. Mamiya T, et al. 2008. Hepatocyte-specific deletion of heme oxygenase-1 disrupts redox homeostasis in basal and oxidative environments. Tohoku J. Exp. Med. 216:331–339 [DOI] [PubMed] [Google Scholar]
- 21. Motohashi H, Shavit J, Igarashi K, Yamamoto M, Engel JD. 1997. The world according to Maf. Nucleic Acids Res. 25:2953–2959 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Motohashi H, O'Connor T, Katsuoka F, Engel JD, Yamamoto M. 2002. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294:1–12 [DOI] [PubMed] [Google Scholar]
- 23. Motohashi H, Katsuoka F, Engel JD, Yamamoto M. 2004. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. U. S. A. 101:6379–6384 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Motohashi H, et al. 2006. MafG sumoylation is required for active transcriptional repression. Mol. Cell. Biol. 26:4652–4663 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Motohashi H, et al. 2010. NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation. Blood 115:677–686 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Niwa H, et al. 1993. An efficient gene-trap method using poly A trap vectors and characterization of gene-trap events. J. Biochem. 113:343–349 [DOI] [PubMed] [Google Scholar]
- 27. Okada K, et al. 2008. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G735–G747 [DOI] [PubMed] [Google Scholar]
- 28. Onodera K, et al. 1999. Characterization of the murine mafF gene. J. Biol. Chem. 274:21162–21169 [DOI] [PubMed] [Google Scholar]
- 29. Onodera K, Shavit JA, Motohashi H, Yamamoto M, Engel JD. 2000. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice. EMBO J. 19:1335–1345 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. 2010. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49:1603–1616 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Romeo PH, et al. 1990. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 344:447–449 [DOI] [PubMed] [Google Scholar]
- 32. Rushmore TH, Morton MR, Pickett CB. 1991. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:11632–11639 [PubMed] [Google Scholar]
- 33. Shavit JA, et al. 1998. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev. 12:2164–2174 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Shi ZZ, et al. 2000. Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc. Natl. Acad. Sci. U. S. A. 97:5101–5106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Shivdasani RA, et al. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development. Cell 81:695–704 [DOI] [PubMed] [Google Scholar]
- 36. Sun J, et al. 2002. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 21:5216–5224 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Takagi Y, et al. 2004. MafT, a new member of the small Maf protein family in zebrafish. Biochem. Biophys. Res. Commun. 320:62–69 [DOI] [PubMed] [Google Scholar]
- 38. Tanimizu N, Nishikawa M, Saito H, Tsujimura T, Miyajima A. 2003. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J. Cell Sci. 116:1775–1786 [DOI] [PubMed] [Google Scholar]
- 39. Wakabayashi N, et al. 2003. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35:238–245 [DOI] [PubMed] [Google Scholar]
- 40. Yamamoto T, et al. 2006. Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements. Genes Cells 11:575–591 [DOI] [PubMed] [Google Scholar]
- 41. Zollner G, et al. 2006. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G923–G932 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







